50 MG Tigecycline For Injection USP

Get a Price/Quote

MOQ : 50 Vials

50 MG Tigecycline For Injection USP Specification

Salt Composition
Each vial contains Tigecycline 50 mg

Packaging Type
Box with vial

Dosage Form
Injection (for IV use after reconstitution)

Life Span
See manufacturers expiry date on packaging

Brand Name
VENZURA (for demonstration, YOUR BRAND)

Indication
Complicated intra-abdominal and skin/soft tissue infections, community-acquired bacterial pneumonia

Pacakaging (Quantity Per Box)
1 vial per box

Origin of Medicine
Manufactured by SANOFI or as per branding

Drug Type
Prescription Antibacterial Injection

Ingredients
Tigecycline USP

Physical Form
Lyophilized Powder

Function
Antibiotic; inhibits bacterial protein synthesis

Recommended For
Adults with complicated infections

Dosage
50 mg per vial, for intravenous infusion after reconstitution

Dosage Guidelines
As directed by the physician, usually administered every 12 hours

Suitable For
Adults and adolescents (as prescribed by physician)

Quantity
1 Lyophilized Vial per box

Storage Instructions
Store below 25C, protected from light

Prescription Status
Rx Only

Therapeutic Class
Glycylcycline Antibiotic

Concentration After Reconstitution
10 mg/mL

Approval
US FDA / DCGI approved formulation

Reconstitution Instructions
Reconstitute with 5.3 mL of 0.9% sodium chloride or 5% dextrose injection before IV infusion

Appearance
Yellow-orange lyophilized powder

Administration Route
Intravenous (IV) only

50 MG Tigecycline For Injection USP Trade Information

Minimum Order Quantity
50 Vials

Payment Terms
Cash in Advance (CID)

Supply Ability
1000 Vials Per Month

Delivery Time
2-5 Days

Main Domestic Market
All India

About 50 MG Tigecycline For Injection USP

Grab the finest value with VENZURA 50 MG Tigecycline For Injection USP, a premier, redoubtable solution for complicated infections. Featured at a reduced price, this towering antibiotic boasts FDA/DCGI-approved quality and is crafted by SANOFI or your trusted supplier in India. Each lyophilized vial contains 50 mg of Tigecycline USP, for convenient IV infusion after reconstitution. Expertly inhibits bacterial protein synthesis, making it ideal for adults and adolescents as prescribed. Packaged for protection, store below 25C, and benefit from its superior efficacy in clinical care.

Usage, Applications & Features of 50 MG Tigecycline For Injection USP

Indicated for complicated intra-abdominal and skin/soft tissue infections and community-acquired bacterial pneumonia, 50 MG Tigecycline For Injection USP is intended for intravenous use after careful reconstitution. This prescription-only glycyclcycline antibiotic is suitable for adults and adolescents under physician guidance. With a robust capacity to target bacterial protein synthesis, its yellow-orange lyophilized powder formulation ensures swift integration into hospital and clinical protocols, offering notable efficiency and safety across diverse medical settings.

Payment Terms, Delivery Logistics & Export Market for Tigecycline Injection

We facilitate seamless payment terms with flexible options including advance payment and secure transactions. Upon order confirmation, we expedite goods transport and ensure reliable handover of neatly packaged vials-each box containing one vial. Typical delivery time ranges from 3-15 days depending on export destination. Our main export markets include Asia, Africa, the Middle East, and emerging regions, with all shipments packaged securely to preserve product integrity during international transit.

FAQ's of 50 MG Tigecycline For Injection USP:

Q: How should I reconstitute 50 MG Tigecycline For Injection USP before administration?

A: Reconstitute each vial with 5.3 mL of either 0.9% sodium chloride or 5% dextrose injection to achieve a concentration of 10 mg/mL for intravenous infusion.

Q: What are the primary therapeutic uses of Tigecycline Injection?

A: It is primarily used for treating complicated intra-abdominal infections, skin and soft tissue infections, and community-acquired bacterial pneumonia, as prescribed by a healthcare professional.

Q: When should this injection be administered?

A: VENZURA Tigecycline injection is typically administered every 12 hours or as directed by your physician, following reconstitution and only via intravenous infusion.

Q: Where is this medication manufactured and approved for use?

A: This formulation is manufactured by SANOFI or as per your branding in India and is US FDA and DCGI approved for use in clinical settings.

Q: What benefits does this antibiotic offer over alternatives?

A: Tigecycline presents a redoubtable action against a wide spectrum of bacteria, effectively inhibiting bacterial protein synthesis where other antibiotics may not suffice, especially for complicated infections.

Q: What is the process for storing and handling this injection?

A: Store the vial below 25C and protect from light. Ensure it remains in its original packaging until reconstitution and follow all expiration dates as noted by the manufacturer.